UK NICE · March 25, 2026

Better data for better decisions

NICE publishes EQ-5D-5L value set to support health technology assessment and NHS reimbursement decisions.

Low obligation Framework Market Access & Reimbursement Health Data, Privacy & Security UK Health technology assessmentReimbursement

Sophie Cooper, senior scientific adviser in NICE’s science policy team, explains the importance of the recently published EQ-5D-5L value set and how it has the potential to help us decide if new treatments offer good value for money for the NHS.

Read the official source ↗

Published by UK NICE. HealthSignal links to the original document; the summary above is extracted from the source text.